000352197 000__ 01616cam\a2200349\a\4500
000352197 001__ 352197
000352197 005__ 20210513130116.0
000352197 008__ 900823s1988\\\\mdu\\\\\\\\\\\100\0\eng\\
000352197 019__ $$a18696659$$a19077417$$a21939731
000352197 035__ $$a(OCoLC)ocm22542263
000352197 035__ $$a352197
000352197 040__ $$aNLM$$cNLM$$dPAU$$dAJB$$dGPO$$dVET$$dMDU$$dZHM$$dCGC$$dSYB$$dGEBAY$$dISE
000352197 049__ $$aISEA
000352197 050_4 $$aRC564$$b.B615 1988
000352197 074__ $$a831-C-8
000352197 08204 $$a362.293
000352197 0860_ $$aHE 20.8216:89
000352197 24500 $$aBiological vulnerability to drug abuse /$$ceditors, Roy W. Pickens, Dace S. Svikis.
000352197 260__ $$aRockville, Md. (5600 Fishers Lane, Rockville 20857) :$$bU.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse,$$c[1988]
000352197 300__ $$aviii, 185 p. :$$bill. ;$$c24 cm.
000352197 440_0 $$aNIDA research monograph ;$$v89.
000352197 500__ $$aDHHS publication ; no. (ADM) 88-1590.
000352197 500__ $$aBased the proceedings of a technical review on biological vulnerability to drug abuse held on June 2-3, 1986, in Rockville, Md.; sponsored by the Office of Science and the Division of Clinical Research of the National Institute on Drug Abuse.
000352197 504__ $$aIncludes bibliographical references.
000352197 650_0 $$aDrug abuse$$xGenetic aspects.
000352197 650_0 $$aBehavior genetics.
000352197 650_0 $$aPharmacogenetics.
000352197 7001_ $$aPickens, Roy W.
000352197 7001_ $$aSvikis, Dace S.
000352197 7102_ $$aNational Institute on Drug Abuse.$$bOffice of Science.
000352197 7102_ $$aNational Institute on Drug Abuse.$$bDivision of Clinical Research.
000352197 830_0 $$aDHHS publication ;$$vno. (ADM) 88-1590.
000352197 85200 $$bgen$$hRC564$$i.B615$$i1988
000352197 909CO $$ooai:library.usi.edu:352197$$pGLOBAL_SET
000352197 980__ $$aBIB
000352197 980__ $$aBOOK